Key result
Stem cell-derived exosomes protect against myocardial reperfusion injury via anti-apoptotic and pro-angiogenic effects.
Why the study?
Stem cell efficacy in post-ischaemic myocardium is limited by rapid degradation, leading to interest in stem cell-derived exosomes as an alternative regenerative approach against ischaemia and reperfusion injury.
Do stem cell-derived exosomes improve cardiac repair and protect against myocardial reperfusion injury in post-ischaemic myocardium?
Do stem cell-derived exosomes improve cardiac repair and protect against myocardial reperfusion injury in post-ischaemic myocardium?
Stem cell-derived exosomes represent a promising cell-free therapeutic approach for cardiac repair and protection against reperfusion injury following myocardial ischaemia.
May support exosome therapy for ischaemic repair; leaves open need for randomized human trials before practice change.
Myocardial ischaemia continues to be a predominant global cause of mortality, leaving survivors with compromised quality of life and significant loss of functional cardiomyocytes. The main therapeutic approach, which attempts to restore heart function, generally involves myocardial reperfusion. However, this intervention is frequently complicated by the occurrence of myocardial reperfusion injury, which undermines its therapeutic benefits. Consequently, there is an increasing focus on alternative regenerative approaches, such as stem and progenitor cell therapies. Since their initial and successful use in oncology, stem cells have emerged as promising tools for mitigating various pathological conditions. Nonetheless, their efficacy in post-ischaemic myocardial environments is questioned due to their rapid degradation following delivery. Interestingly, small extracellular vesicles, particularly exosomes secreted by stem cells, demonstrate reparative properties akin to those of the stem cells themselves. Indeed, evidence strongly shows that exosomes derived from mesenchymal stem cells, cardiac progenitor cells, and induced pluripotent stem cells exert anti-apoptotic and pro-angiogenic effects in post-ischaemic cardiomyocytes while concomitantly offering protection against myocardial reperfusion injury. In this review, we critically appraise the pivotal findings supporting the potential clinical application of stem cell-derived exosomes, and underscore key considerations necessary to optimise their therapeutic efficacy.
No takes yet. Share an insight, caveat, or question.
Yazbeck et al. (2025) conducted a review in Myocardial ischaemia. Stem cell-derived exosomes was evaluated. Stem cell-derived exosomes demonstrate reparative properties, exerting anti-apoptotic and pro-angiogenic effects in post-ischaemic cardiomyocytes and protecting against myocardial reperfusion injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: